Novel 3-trifluoromethyl-1,2,4-oxadiazole analogues of astemizole with multi-stage antiplasmodium activity and in vivo efficacy in a Plasmodium berghei mouse malaria infection model
dc.contributor.author | Mambwe, Dickson | |
dc.contributor.author | Korkor, Constance M. | |
dc.contributor.author | Mabhula, Amanda | |
dc.contributor.author | Ngqumba, Zama | |
dc.contributor.author | Cloete, Cleavon | |
dc.contributor.author | Kumar, Malkeet | |
dc.contributor.author | Barros, Paula Ladeia | |
dc.contributor.author | Leshabane, Meta Kgaogelo | |
dc.contributor.author | Coertzen, Dina | |
dc.contributor.author | Taylor, Dale | |
dc.contributor.author | Gibhard, Liezl | |
dc.contributor.author | Njoroge, Mathew | |
dc.contributor.author | Lawrence, Nina | |
dc.contributor.author | Reader, Janette | |
dc.contributor.author | Moreira, Diogo Rodrigo | |
dc.contributor.author | Birkholtz, Lyn-Marie | |
dc.contributor.author | Wittlin, Sergio | |
dc.contributor.author | Egan, Timothy J. | |
dc.contributor.author | Chibale, Kelly | |
dc.date.accessioned | 2023-02-24T08:08:34Z | |
dc.date.issued | 2022-12 | |
dc.description.abstract | Please read abstract in the article. | en_US |
dc.description.department | Biochemistry | en_US |
dc.description.department | Genetics | en_US |
dc.description.department | Microbiology and Plant Pathology | en_US |
dc.description.department | UP Centre for Sustainable Malaria Control (UP CSMC) | en_US |
dc.description.embargo | 2023-12-12 | |
dc.description.librarian | hj2023 | en_US |
dc.description.uri | http://pubs.acs.org/loi/jmcmar | en_US |
dc.identifier.citation | Mambwe, D., Korkor, C.M., Mabhula, A. et al. 2022, 'Novel 3-trifluoromethyl-1,2,4-oxadiazole analogues of astemizole with multi-stage antiplasmodium activity and in vivo efficacy in a Plasmodium berghei mouse malaria infection model', Journal of Medicinal Chemistry, vol. 65, no. 24, pp. 16695–16715, doi : 10.1021/acs.jmedchem.2c01516. | en_US |
dc.identifier.issn | 0022-2623 (print) | |
dc.identifier.issn | 1520-4804 (online) | |
dc.identifier.other | 10.1021/acs.jmedchem.2c01516 | |
dc.identifier.uri | https://repository.up.ac.za/handle/2263/89809 | |
dc.language.iso | en | en_US |
dc.publisher | American Chemical Society | en_US |
dc.rights | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Medicinal Chemistry, © 2022 American Chemical Society after peer review and technical editing by the publisher. [12 months embargo] | en_US |
dc.subject | Astemizole | en_US |
dc.subject | Repositioning | en_US |
dc.subject | Plasmodium falciparum | en_US |
dc.subject | Plasmodium berghei | en_US |
dc.subject | Human ether-á-go-go-related gene (hERG) | en_US |
dc.subject | Live-cell microscopy | en_US |
dc.title | Novel 3-trifluoromethyl-1,2,4-oxadiazole analogues of astemizole with multi-stage antiplasmodium activity and in vivo efficacy in a Plasmodium berghei mouse malaria infection model | en_US |
dc.type | Postprint Article | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.75 KB
- Format:
- Item-specific license agreed upon to submission
- Description: